These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16740164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization.
    Maguire RA, Bergman N, Phillips DM.
    Sex Transm Dis; 2001 May; 28(5):259-65. PubMed ID: 11354263
    [Abstract] [Full Text] [Related]

  • 4. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
    Fernández-Romero JA, Abraham CJ, Rodriguez A, Kizima L, Jean-Pierre N, Menon R, Begay O, Seidor S, Ford BE, Gil PI, Peters J, Katz D, Robbiani M, Zydowsky TM.
    Antimicrob Agents Chemother; 2012 Jan; 56(1):358-68. PubMed ID: 22064530
    [Abstract] [Full Text] [Related]

  • 5. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.
    Moench TR, Mumper RJ, Hoen TE, Sun M, Cone RA.
    BMC Infect Dis; 2010 Nov 18; 10():331. PubMed ID: 21087496
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis.
    Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA.
    Sex Transm Dis; 2002 Nov 18; 29(11):655-64. PubMed ID: 12438901
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.
    Nixon B, Jandl T, Teller RS, Taneva E, Wang Y, Nagaraja U, Kiser PF, Herold BC.
    Antimicrob Agents Chemother; 2014 Nov 18; 58(2):1153-60. PubMed ID: 24323471
    [Abstract] [Full Text] [Related]

  • 15. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.
    Roy S, Gourde P, Piret J, Désormeaux A, Lamontagne J, Haineault C, Omar RF, Bergeron MG.
    Antimicrob Agents Chemother; 2001 Jun 18; 45(6):1671-81. PubMed ID: 11353610
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.
    Shankar GN, Alt C.
    J Antimicrob Chemother; 2014 Dec 18; 69(12):3282-93. PubMed ID: 25139839
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.
    Herbst-Kralovetz MM, Pyles RB.
    J Virol; 2006 Oct 18; 80(20):9988-97. PubMed ID: 17005677
    [Abstract] [Full Text] [Related]

  • 19. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM.
    Curr Pharm Des; 2004 Oct 18; 10(3):315-36. PubMed ID: 14754390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.